Nektar Therapeutics 2017 JP Morgan Healthcare Conference

Loading viewer...

conference

Format: PDF conference

Nektar Therapeutics presents its biopharmaceutical pipeline and growth strategy at the 2017 JP Morgan Healthcare Conference. The presentation outlines proprietary drug candidates including NKTR-181, NKTR-214, NKTR-358, and NKTR-262, with projected annual revenue of $375-450M by 2021, supported by integrated R&D and manufacturing capabilities.

Browse all conferences →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Nektar Therapeutics

View all →

Nektar Therapeutics 2017 Cowen Healthcare Conference

conference

31 Pages

Nektar Therapeutics NKTR-214 Short Report 2018

other

Similar conferences from other companies

Browse all →

SGL Carbon Investor Presentation Berenberg European Conference 2019

conference

45 Pages

SGL Carbon

Open RAN Technical Architecture & Multi-Vendor Ecosystem | 5G Americas

conference